The company is evaluating the use of fully human intranasal anti-CD3 monoclonal antibody foralumab for the treatment of patients with Secondary Progressive Multiple Sclerosis in a phase 2a study. The ...

A new study found that combining cognitive behavioral therapy (CBT) and a wakefulness medication significantly improved levels of fatigue in patients with multiple sclerosis (MS). The findings may ...

Quantum BioPharma Ltd. announced the completion of dosing in 90-day oral toxicity and toxicokinetic studies for its drug Lucid-21-302 (Lucid-MS), aimed at treating Multiple Sclerosis (MS). This ...

FRANKFURT (Reuters) -Roche's experimental multiple sclerosis drug achieved its main goal in one of two key late-stage trials testing it against the relapsing form of the disease, the Swiss drugmaker ...

Fampridine, a drug used to improve walking in people with multiple sclerosis, may also improve working memory in certain healthy individuals. The findings pave the way for potential new treatments for ...

The Congressional Budget Office (CBO) informs Congress about the costs or revenue changes associated with proposed legislation, a challenging enough task on its own. Sometimes, the CBO is asked to ...

Women under age 40 with multiple sclerosis are 8 percent less likely than men to receive disease-modifying drugs, a new study has found. Uncertainty about the impact of these drugs during pregnancy ...

New research from the USC Schaeffer Center shows how these barriers may come at a cost to patients' health. In a large study of Medicare beneficiaries with multiple sclerosis (MS), researchers found ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Even women with more severe MS cases are less likely than men to get critical treatments, a new study finds. Women under age 40 with multiple sclerosis are 8 percent less likely than men to receive ...